Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Mucosal Immunology

• Publication date

  2012-08-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/mi.2012.82PMID 22929559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial

  2012cited by this paper
• Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.

  2012cited by this paper
• Intraepithelial γδ T Cells Remain Increased in the Duodenum of AIDS Patients Despite Antiretroviral Treatment

  2012cited by this paper
• The Effect of Intermittent IL-2 Therapy on CD4 T Cells in the Gut in HIV-1–Infected Patients

  2011cited by this paper
• The Gut Mucosal Viral Reservoir in HIV-Infected Patients Is Not the Major Source of Rebound Plasma Viremia following Interruption of Highly Active Antiretroviral Therapy

  2011cited by this paper
• HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS.

  2011cited by this paper
• Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy

  2011cited by this paper
• Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations With Immune Activation

  2011cited by this paper
• Altered distribution of mucosal NK cells during HIV infection

  2011cited by this paper
• Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections

  2010cited by this paper
• A Role for Syndecan-1 and Claudin-2 in Microbial Translocation During HIV-1 Infection

  2010cited by this paper
• Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

  2010cited by this paper
• Mechanisms underlying γδ T-cell subset perturbations in SIV-infected Asian rhesus macaques.

  2010cited by this paper
• Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.

  2010cited by this paper
• Th17 and regulatory T cells: implications for AIDS pathogenesis

  2010cited by this paper
• Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection

  2010cited by this paper
• Th17 cells, HIV and the gut mucosal barrier

  2010cited by this paper
• Polyclonal B Cell Differentiation and Loss of Gastrointestinal Tract Germinal Centers in the Earliest Stages of HIV-1 Infection

  2009cited by this paper
• Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

  2009cited by this paper
• Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection

  2009cited by this paper
• Cycling of Gut Mucosal CD4+ T Cells Decreases after Prolonged Anti-Retroviral Therapy and is Associated with Plasma LPS Levels

  2009cited by this paper
• Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.

  2009cited by this paper
• Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses

  2008cited by this paper
• The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche.

  2008cited by this paper
• Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients

  2008cited by this paper
• Immune reconstitution in the sigmoid colon after long-term HIV therapy

  2008cited by this paper
• Magnitude and Complexity of Rectal Mucosa HIV-1-Specific CD8+ T-Cell Responses during Chronic Infection Reflect Clinical Status

  2008cited by this paper
• Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients

  2008cited by this paper
• Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.

  2008cited by this paper
• Pathogenesis of HIV in the gastrointestinal tract

  2007cited by this paper
• Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production.

  2007cited by this paper
• Multifunctional Human Immunodeficiency Virus (HIV) Gag-Specific CD8+ T-Cell Responses in Rectal Mucosa and Peripheral Blood Mononuclear Cells during Chronic HIV Type 1 Infection

  2007cited by this paper
• Compartmentalization of the gut viral reservoir in HIV-1 infected patients

  2007cited by this paper
• Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals

  2007cited by this paper
• Resident Vδ1+ γδ T Cells Control Early Infiltration of Neutrophils after Escherichia coli Infection via IL-17 Production1

  2007cited by this paper
• Evolution of innate and adaptive effector cell functions during acute HIV-1 infection.

  2007cited by this paper
• Rapid Onset of Intestinal Epithelial Barrier Dysfunction in Primary Human Immunodeficiency Virus Infection Is Driven by an Imbalance between Immune Response and Mucosal Repair and Regeneration

  2007cited by this paper
• Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection

  2006cited by this paper
• Massive Infection and Loss of Memory CD4+ T Cells in Multiple Tissues During Acute SIV Infection

  2006cited by this paper
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection

  2006cited by this paper
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection

  2006cited by this paper
• Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection

  2006cited by this paper
• Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.

  2006cited by this paper
• Early Antiretroviral Therapy for Simian Immunodeficiency Virus Infection Leads to Mucosal CD4+ T-Cell Restoration and Enhanced Gene Expression Regulating Mucosal Repair and Regeneration

  2005cited by this paper
• Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors.

  2005cited by this paper
• Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

  2005cited by this paper
• Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract

  2004cited by this paper
• Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy

  2004cited by this paper
• Acquired and natural memory T cells join forces at the mucosal front line

  2004cited by this paper
• CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

  2004cited by this paper
• Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy

  2003cited by this paper
• Trafficking of Human Immunodeficiency Virus Type 1-Specific CD8+ T Cells to Gut-Associated Lymphoid Tissue during Chronic Infection

  2003cited by this paper
• Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.

  2002cited by this paper
• Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.

  2002cited by this paper
• Virologic and Immunologic Effect of Antiretroviral Therapy on HIV‐1 in Gut‐Associated Lymphoid Tissue

  2001cited by this paper
• Preferential and persistent depletion of CCR5+ T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection.

  2001cited by this paper
• Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity.

  1999cited by this paper
• Current concepts in mucosal immunity. III. Ontogeny and function of gamma delta T cells in the intestine.

  1998cited by this paper
• Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis

  1998cited by this paper
• HIV enteropathy: comparative morphometry of the jejunal mucosa of HIV infected patients resident in the United Kingdom and Uganda

  1998cited by this paper
• Functional expression of a truncated Ca2+-activated Cl- channel and activation by phorbol ester.

  1998cited by this paper
• III. Ontogeny and function of γδ T cells in the intestine.

  1998cited by this paper
• The anatomical basis of intestinal immunity

  1997cited by this paper
• Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS

  1996cited by this paper
• Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

  1996cited by this paper
• Virus‐specific antibody production and polyclonal B‐cell activation in the intestinal mucosa of HIV‐infected individuals

  1995cited by this paper
• Enteric Immunologic Abnormalities in Human Immunodeficiency Virus Infection

  1992cited by this paper
• Enteropathy associated with the acquired immunodeficiency syndrome.

  1984cited by this paper
• The origin and antigen-dependent distribution of IgA-containing cells in the intestine

  1978cited by this paper

• Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infection.

  2026cites this paper
• Interplay between viral infections and gut microbiota dysbiosis: Mechanisms and therapeutic potential

  2026cites this paper
• Impact of Oral Cannabinoids on the Endocannabinoidome and Gut Microbiome in People with HIV on Antiretroviral Therapy (CTN PT028 Pilot Clinical Trial).

  2025cites this paper
• A Canadian Survey of Research on HIV-1 Latency—Where Are We Now and Where Are We Heading?

  2024cites this paper
• The role of the HIV-1 gut reservoir in driving early cardiovascular events in people living with HIV

  2024cites this paper
• A biomarker profile reflective of preserved thymic function is associated with reduced comorbidities in ageing people with HIV: an AGEhIV Cohort analysis.

  2024cites this paper
• Intestinal endothelial cells increase HIV infection and latency in resting and activated CD4 + T cells, particularly affecting CCR6 + CD4 + T cells

  2023cites this paper
• Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications

  2023cites this paper
• Impact of Heroin and HIV on Gut Integrity and Immune Activation

  2022cites this paper
• Cannabinoids: Therapeutic Use in Clinical Practice

  2022cites this paper
• Impaired differentiation of small airway basal stem/progenitor cells in people living with HIV

  2022cites this paper
• Cardiovascular Disease and Thrombosis in HIV Infection

  2022cites this paper
• Jejunal epithelial barrier disruption triggered by reactive oxygen species in early SIV infected rhesus macaques.

  2021cites this paper
• Environmental Pollutants, Mucosal Barriers, and Pathogen Susceptibility; The Case for Aflatoxin B1 as a Risk Factor for HIV Transmission and Pathogenesis

  2021cites this paper
• Infectious Colitis

  2021cites this paper
• Equal contributions of feline immunodeficiency virus and coinfections to morbidity in African lions

  2021cites this paper
• Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-Responders

  2021cites this paper
• Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction

  2020cites this paper
• Reply to: Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C.

  2020cites this paper
• High microbial translocation limits gut immune recovery during short-term HAART in the area with high prevalence of foodborne infection.

  2020cites this paper
• Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?

  2020cites this paper
• Cannabinoids and inflammation: Implications for People Living with HIV.

  2019cites this paper
• The Oral, Genital and Gut Microbiome in HIV Infection

  2019cites this paper
• Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

  2019cites this paper
• Gut Microbiome in HIV Infection: Overcoming Barriers?

  2019cites this paper
• Probiotics to manage inflammation in HIV infection.

  2019cites this paper
• Health Outcomes, Pathogenesis and Epidemiology of Severe Acute Malnutrition (HOPE-SAM): rationale and methods of a longitudinal observational study

  2019cites this paper
• Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy

  2019cites this paper
• Intestinal CD4 Depletion in HIV / SIV Infection.

  2019cites this paper
• HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells

  2019cites this paper
• Mechanisms regulating expansion of CD8+ T cells during HIV‐1 infection

  2018cites this paper
• Combating the HIV reservoirs

  2018cites this paper
• Visualizing the Immune System: Providing Key Insights into HIV/SIV Infections

  2018cites this paper
• Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy

  2018cites this paper
• Marked Enteropathy in an Accelerated Macaque Model of AIDS.

  2017cites this paper
• HIV and the Intestine

  2016cites this paper
• Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection

  2016cites this paper
• Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients

  2016cites this paper
• HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial

  2016cites this paper
• Comparative Analysis of Immune Activation Markers of CD8+ T Cells in Lymph Nodes of Different Origins in SIV-Infected Chinese Rhesus Macaques

  2016cites this paper
• Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation

  2016cites this paper
• Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy

  2016cites this paper
• CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals

  2016cites this paper
• HIV-TB co-infection: mechanisms that drive reactivation of Mycobacterium tuberculosis in HIV infection.

  2016cites this paper
• Impact of early cART in the gut during acute HIV infection.

  2016influential citation
• Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis

  2016cites this paper
• Profile of interleukin-22 in gut mucosal health and disease

  2016cites this paper
• LUANDA MARA DA SILVA OLIVEIRA Avaliação fenotípica das células T CD4+ reguladoras, Th17, Th22 e Tc22 nos indivíduos expostos não infectados por HIV-1

  2016cites this paper
• Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection

  2015cites this paper
• Gut commensal microbes do not represent a dominant antigenic source for continuous CD4+ T‐cell activation during HIV‐1 infection

  2015cites this paper
• [Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].

  2015influential citation
• Blood-brain barrier disruption in multiple sclerosis

  2015cites this paper
• Expression of gut‐homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV‐1‐infected patients?

  2015cites this paper
• Persisting high prevalence of pneumococcal carriage among HIV-infected adults receiving antiretroviral therapy in Malawi: a cohort study

  2015cites this paper
• Interleukin 23 produced by myeloid dendritic cells contributes to T-cell dysfunction in HIV type 1 infection by inducing SOCS1 expression.

  2015cites this paper
• Quantification of HIV-1 Proviral DNA Forms in Gut Tissues Using Real-Time PCR

  2015cites this paper
• Site-Specific Differences in T Cell Frequencies and Phenotypes in the Blood and Gut of HIV-Uninfected and ART-Treated HIV+ Adults

  2015cites this paper
• Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

  2015cites this paper
• Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals.

  2014influential citation
• The Role of Gut Mucosal Immunology in HIV Immunopathogenesis

  2014cites this paper
• Mucosal Immunity to HIV-1

  2014cites this paper
• Nausea, Vomiting, and Noninflammatory Diarrhea

  2014cites this paper
• Immune and genetic gardening of the intestinal microbiome

  2014cites this paper
• A multisystem investigation of raltegravir association with intestinal tissue: implications for pre-exposure prophylaxis and eradication.

  2014cites this paper
• HIV enteropathy and aging: gastrointestinal immunity, mucosal epithelial barrier, and microbial translocation.

  2014cites this paper
• Las células natural killer y su papel en la respuesta inmunitaria durante la infección por el virus de la inmunodeficiencia humana tipo-1

  2014cites this paper
• A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects

  2014cites this paper
• Gut Microbiota in HIV Infection: Implication for Disease Progression and Management

  2014cites this paper
• Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.

  2014cites this paper
• Noncommunicable Diseases in HIV Infection in Low- and Middle-Income Countries: Gastrointestinal, Hepatic, and Nutritional Aspects

  2014cites this paper
• Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial

  2014cites this paper
• Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies

  2014cites this paper
• Gastrointestinal Viral Load and Enteroendocrine Cell Number Are Associated with Altered Survival in HIV-1 Infected Individuals

  2013cites this paper
• Oncolytic Viruses as a Potential Approach to Eliminate the HIV Reservoir

  2013cites this paper
• Is there any room for therapeutic vaccination against the HIV-1/AIDS?

  2013cites this paper
• Reconstitution of Intestinal CD 4 and Th 17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects : Implication for Residual Immune Activation from the Results of a Clinical Trial

  year unknowncites this paper